Shopping Cart 0
Cart Subtotal
USD 0

Sutro Biopharma Inc (STRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADC's), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways. Its pipeline portfolio includes STRO-001, a CD74 ADC for the treatment of multiple myeloma, lymphomas, diffuse large B-cell lymphoma (DLBCL) and Mantle cell lymphoma (MCL); STRO-002, targeting ovarian and endometrial cancer. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system which develops therapeutic proteins and discovers drugs for the treatment and prevention of diseases. Sutro Biopharma owns a manufacturing facility in San Carlos, California. The company works in partnership with various pharmaceutical and biotechnology companies for pre-clinical development of novel antibody drug conjugates. Sutro Biopharma is headquartered in South San Francisco, California, the US.

Sutro Biopharma Inc (STRO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sutro Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Sutro Biopharma Raises USD85.4 Million in Series E Financing 11

Sutro Biopharma Raises USD60 Million in Venture Financing 13

SutroVax Raises Funds Through Initial Financing Round 14

Sutro Biopharma Raises USD 26 Million In Series D Financing 15

Sutro Biopharma Raises USD 16.5 Million In Second Tranche Of Series C Financing 17

Partnerships 19

Sutro Biopharma and Leukemia & Lymphoma Society Enter into Partnership 19

Sutro Biopharma Amends Co-Development Agreement with Celgene 20

Sutro Biopharma Enters into Agreement with University of California, San Francisco 22

Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 23

Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 24

Sutro Biopharma Enters Into Co-Development Agreement With Celgene 25

Licensing Agreements 26

Merck Enters into Licensing Agreement with Sutro Biopharma 26

EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 27

EMD Serono Enters into Licensing Agreement with Sutro Biopharma 28

Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 29

Equity Offering 30

Sutro Biopharma Prices IPO of Shares for USD85 Million 30

SutroVax Spins Out from Sutro Biopharma 31

Sutro Biopharma Inc-Key Competitors 32

Sutro Biopharma Inc-Key Employees 33

Sutro Biopharma Inc-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Recent Developments 35

Financial Announcements 35

Nov 14, 2018: Sutro Biopharma announces third quarter 2018 financial results 35

Corporate Communications 37

Nov 08, 2018: Sutro appoints industry veteran Shalini Sharp to board of directors 37

Sep 12, 2018: Sutro Biopharma names Worsley as Chief Business Officer and Linda Fitzpatrick as People and Communications Chief 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List Of Figure

List of Figures

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sutro Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sutro Biopharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Sutro Biopharma Raises USD85.4 Million in Series E Financing 11

Sutro Biopharma Raises USD60 Million in Venture Financing 13

SutroVax Raises Funds Through Initial Financing Round 14

Sutro Biopharma Raises USD 26 Million In Series D Financing 15

Sutro Biopharma Raises USD 16.5 Million In Second Tranche Of Series C Financing 17

Sutro Biopharma and Leukemia & Lymphoma Society Enter into Partnership 19

Sutro Biopharma Amends Co-Development Agreement with Celgene 20

Sutro Biopharma Enters into Agreement with University of California, San Francisco 22

Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 23

Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 24

Sutro Biopharma Enters Into Co-Development Agreement With Celgene 25

Merck Enters into Licensing Agreement with Sutro Biopharma 26

EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 27

EMD Serono Enters into Licensing Agreement with Sutro Biopharma 28

Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 29

Sutro Biopharma Prices IPO of Shares for USD85 Million 30

SutroVax Spins Out from Sutro Biopharma 31

Sutro Biopharma Inc, Key Competitors 32

Sutro Biopharma Inc, Key Employees 33

Sutro Biopharma Inc, Other Locations 34

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sutro Biopharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.